{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T22:37:06Z","timestamp":1789857426618,"version":"4.0.1"},"reference-count":112,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":2156,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.fertnstert.2016.05.011","type":"journal-article","created":{"date-parts":[[2016,5,28]],"date-time":"2016-05-28T15:00:06Z","timestamp":1464447606000},"page":"16-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":141,"title":["Environmental determinants of\u00a0polycystic ovary syndrome"],"prefix":"10.1016","volume":"106","author":[{"given":"Sharon Stein","family":"Merkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Phy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia K.","family":"Sites","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongzi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2016.05.011_bib1","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib2","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1530\/REP-14-0499","article-title":"Pathogenesis of polycystic ovary syndrome: multifactorial assessment from the foetal stage to menopause","volume":"150","author":"de Melo","year":"2015","journal-title":"Reproduction"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1210\/er.2004-0004","article-title":"The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome","volume":"26","author":"Escobar-Morreale","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2147\/IJWH.S55748","article-title":"A life course perspective on polycystic ovary syndrome","volume":"6","author":"Sanchez","year":"2014","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Med"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1196\/annals.1365.014","article-title":"Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age","volume":"1092","author":"Pasquali","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib7","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1210\/jc.2013-2375","article-title":"Lifecycle of polycystic ovary syndrome (PCOS): From in utero to menopause","volume":"98","author":"Welt","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib8","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1093\/humrep\/deq162","article-title":"High prevalence of polycystic ovary syndrome in women born small for gestational age","volume":"25","author":"Melo","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib9","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/sj.ijo.0802301","article-title":"Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms","volume":"27","author":"Laitinen","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1210\/jc.2007-1800","article-title":"Polycystic ovaries in nonobese adolescents and young women with ovarian androgen excess: relation to prenatal growth","volume":"93","author":"Ib\u00e1\u00f1ez","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib11","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.fertnstert.2008.09.018","article-title":"Treatment of\u00a0obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"92","author":"Moran","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1467-789X.2012.01053.x","article-title":"The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis","volume":"14","author":"Lim","year":"2013","journal-title":"Obes Rev"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib13","first-page":"CD007506","article-title":"Lifestyle changes in women with polycystic ovary syndrome","author":"Moran","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.fertnstert.2007.09.041","article-title":"Consensus on infertility treatment related to polycystic ovary syndrome","volume":"89","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib15","unstructured":"American College of Obstetricians and Gynecologists. Committee opinion: exposure to toxic environmental agents. No. 575, October 2013:1\u20135."},{"key":"10.1016\/j.fertnstert.2016.05.011_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijgo.2015.09.002","article-title":"International Federation of Gynecology and Obstetrics opinion on reproductive health impacts of exposure to toxic environmental chemicals","volume":"131","author":"di Renzo","year":"2015","journal-title":"Int J Gynecol Obstetrics"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1210\/er.2009-0002","article-title":"Endocrine-disrupting chemicals: an Endocrine Society scientific statement","volume":"30","author":"Diamanti-Kandarakis","year":"2009","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib18","series-title":"Environmental impacts on reproductive health and fertility","year":"2010"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib19","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1289\/ehp.1204934","article-title":"Predicting later-life outcomes of early-life exposures","volume":"120","author":"Boekelheide","year":"2012","journal-title":"Environ Health Perspect"},{"issue":"Suppl 12","key":"10.1016\/j.fertnstert.2016.05.011_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1289\/ehp.94102s1255a","article-title":"The wildlife\/human connection: modernizing risk decisions","volume":"102","author":"Colborn","year":"1994","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib21","unstructured":"Food Quality Protection Act of 1996. Pub. L, No. 104\u201370, \u00a7 301, 110 Stat 1489 (1996)."},{"key":"10.1016\/j.fertnstert.2016.05.011_bib22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/toxsci\/kfn030","article-title":"Fifteen years after \u201cWingspread\u201d\u2014environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go","volume":"105","author":"Hotchkiss","year":"2008","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s002449900392","article-title":"The environmental occurrence of herbicides: the importance of degradates in ground water","volume":"35","author":"Kolpin","year":"1998","journal-title":"Arch Environ Contam Toxicol"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib24","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1021\/es011055j","article-title":"Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams 1999\u20132000: a national reconnaissance","volume":"36","author":"Kolpin","year":"2002","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.scitotenv.2004.01.015","article-title":"Urban contribution of pharmaceuticals and other organic wastewater contaminants to streams during differing flow conditions","volume":"328","author":"Kolpin","year":"2004","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1472-6823-14-86","article-title":"Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol A in polycystic ovary syndrome: a case-control study","volume":"14","author":"Vagi","year":"2014","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib27","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1093\/humrep\/dev123","article-title":"Association of serum levels of typical organic pollutants with polycystic ovary syndrome (PCOS): a case-control study","volume":"30","author":"Yang","year":"2015","journal-title":"Hum Rep"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib28","doi-asserted-by":"crossref","first-page":"E480","DOI":"10.1210\/jc.2010-1658","article-title":"Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS","volume":"96","author":"Kandaraki","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib29","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1289\/ehp.0901257","article-title":"Neonatal exposure to bisphenol A and reproductive and endocrine alterations resembling the polycystic ovarian syndrome in adult rats","volume":"118","author":"Fernandez","year":"2010","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1515\/hmbci-2014-0003","article-title":"Endocrine disruptors and polycystic ovary syndrome: a focus on bisphenol A and its potential pathophysiological aspects","volume":"17","author":"Palioura","year":"2014","journal-title":"Horm Mol Biol Clin Investig"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib31","author":"Centers for Disease Control and Prevention. Fourth national report on human exposure to environmental chemicals, updated tables"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib32","series-title":"Casarett and Doull\u2019s toxicology: the basic science of poisons","author":"Klaasen","year":"2013"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib33","first-page":"415","article-title":"Evidence for PCBs as neurodevelopmental toxicants in humans","volume":"18","author":"Jacobson","year":"1997","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib34","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1073\/pnas.76.12.6641","article-title":"Estrogenic activity of the insecticide chlordecone (Kepone) and interaction with uterine estrogen receptors","volume":"76","author":"Hammond","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib35","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.reprotox.2003.10.003","article-title":"NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of 2-bromopropane","volume":"18","author":"Boekelheide","year":"2004","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib36","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1377\/hlthaff.2010.1255","article-title":"Reproductive health and the industrialized food system: a point of intervention for health policy","volume":"30","author":"Sutton","year":"2011","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib37","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1139\/apnm-2014-0073","article-title":"Effect of a low starch, low dairy diet on fat oxidation in overweight and obese women with polycystic ovary syndrome","volume":"39","author":"Pohlmeier","year":"2014","journal-title":"Appl Physiol Nutr Metab"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib38","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000357064","article-title":"Prolactin may be increased in newly diagnosed celiac children and adolescents and decreases after 6 months of gluten-free diet","volume":"81","author":"Delvecchio","year":"2014","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib39","unstructured":"Tolman J. Nature\u2019s hormone factory: endocrine disruptors in the natural environment. 1996. Competitive Enterprise Institute."},{"key":"10.1016\/j.fertnstert.2016.05.011_bib40","unstructured":"United States Environmental Protection Agency. EPA releases screening results of endocrine disruptor screening for 52 pesticide chemical. June 30,\u00a02015."},{"key":"10.1016\/j.fertnstert.2016.05.011_bib41","first-page":"206959","article-title":"Dairy consumption and insulin resistance: the role of body fat, physical activity, and energy intake","author":"Tucker","year":"2015","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib42","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/ajcn\/80.5.1246","article-title":"Glycemia and insulinemia in healthy subjects after lactose equivalent meals of milk and other food proteins: the role of plasma amino acids and incretins","volume":"80","author":"Nilsson","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/ajcn\/82.1.69","article-title":"Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects","volume":"82","author":"Frid","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.foodchem.2014.02.153","article-title":"Estrogenic endocrine disruptors present in sports supplements. A risk assessment for human health","volume":"159","author":"Plotan","year":"2014","journal-title":"Food Chem"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib45","first-page":"2","article-title":"Low starch\/low dairy diet results in successful treatment of obesity and co-morbidities linked to polycystic ovary syndrome (PCOS)","volume":"5","author":"Phy","year":"2015","journal-title":"J Obes Weight Loss Ther"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib46","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.niox.2011.06.005","article-title":"Determinants of insulin responsiveness in young women: impact of polycystic ovarian syndrome, nitric oxide, and vitamin D","volume":"25","author":"Ngo","year":"2011","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib47","first-page":"1","article-title":"Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials","author":"Unfer","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib48","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1210\/jc.2013-1161","article-title":"Metabolic inflexibility is a feature of women with polycystic ovary syndrome and is associated with both insulin resistance and hyperandrogenism","volume":"98","author":"DiSarra","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib49","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib50","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1210\/jc.2015-1957","article-title":"Dietary carbohydrate intake does not impact insulin resistance or androgens in healthy, eumenorrheic women","volume":"11","author":"Sjaarda","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib51","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.fertnstert.2005.12.054","article-title":"Difference in dietary intake between women with polycystic ovary syndrome and healthy controls","volume":"86","author":"Douglas","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib52","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/jcph.362","article-title":"The rationale of the myo-inositol and d-chiro-inositol combined treatment for polycystic ovary syndrome","volume":"54","author":"Dinicola","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib53","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3109\/09513590.2015.1054802","article-title":"Reflections on inositol(s) for PCOS therapy: steps toward success","volume":"31","author":"Nestler","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib54","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejogrb.2015.09.024","article-title":"Results from the international consensus conference on myo-inositol and d-chiro-inositol in obstetrics and gynecology: the link between metabolic syndrome and PCOS","volume":"195","author":"Facchinetti","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib55","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.3390\/nu7064555","article-title":"Serum vitamin D and PCOS: a systematic review and meta-analysis","volume":"6","author":"He","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib56","first-page":"757","article-title":"Effect of vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome women: a pilot study","volume":"10","author":"Wehr","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib57","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1210\/jc.2015-2580","article-title":"Vitamin D supplementation decreases TGF-\u03b21 bioavailability in PCOS: a randomized placebo-controlled trial","volume":"100","author":"Irani","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib58","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/07315724.2012.10720443","article-title":"Omega-3 fatty acids improve glucose metabolism without effects on obesity values and serum visfatin levels in women with polycystic ovary syndrome","volume":"31","author":"Rafraf","year":"2012","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib59","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/cen.12699","article-title":"Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial","volume":"82","author":"Jamilian","year":"2015","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib60","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-0035-1548790","article-title":"Effects of zinc supplementation on markers of insulin resistance and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial","volume":"123","author":"Foroozanfard","year":"2015","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib61","first-page":"1470","article-title":"Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone","volume":"84","author":"Huber-Buchholz","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib62","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/humrep\/deg367","article-title":"Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology, and fertility rate induced by diet","volume":"18","author":"Crosignani","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib63","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","article-title":"Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome","volume":"36","author":"Kiddy","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib64","doi-asserted-by":"crossref","unstructured":"Ollila ME, Piltonen T, Puukka K, Ruokonen A, Jarvelin M, Tapanainen JS, et\u00a0al. J Clin Endocrinol Metab 2016;101:739\u2013747.","DOI":"10.1210\/jc.2015-3543"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib65","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1210\/jc.2007-1834","article-title":"Impact of obesity on the risk for polycystic ovary syndrome","volume":"93","author":"Yildiz","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib66","doi-asserted-by":"crossref","first-page":"E304","DOI":"10.1210\/jc.2010-1290","article-title":"Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance","volume":"96","author":"Manneras-Holm","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib67","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1210\/jc.2007-2117","article-title":"Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome","volume":"93","author":"Barber","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib68","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1210\/jc.2005-1490","article-title":"The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery","volume":"90","author":"Escobar-Morreale","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib69","first-page":"559","article-title":"Resting metabolic rate and postprandial thermogenesis in polycystic ovarian syndrome","volume":"14","author":"Segal","year":"1990","journal-title":"Int J Obes"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib70","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2265.1992.tb02262.x","article-title":"Postprandial thermogenesis is reduced in polycystic ovary syndrome and is associated with increased insulin resistance","volume":"36","author":"Robinson","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib71","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1123\/ijsnem.10.1.71","article-title":"Effect of acute resistance exercise on postexercise oxygen consumption and resting metabolic rate in young women","volume":"10","author":"Osterberg","year":"2000","journal-title":"Int J Sport Nutr Exerc Metab"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib72","first-page":"2586","article-title":"Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome","volume":"80","author":"Holte","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib73","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/humupd\/dmh018","article-title":"Improving reproductive performance in overweight\/obese women with effective weight management","volume":"10","author":"Norman","year":"2004","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib74","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1210\/jc.2002-020815","article-title":"Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome","volume":"88","author":"Moran","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib75","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.fertnstert.2004.02.104","article-title":"A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and\/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study","volume":"82","author":"Hoeger","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib76","first-page":"CD003053","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, d-chiro-inositol) for women with polycystic ovary syndrome, oligoamenorrhoea and subfertility","author":"Tang","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib77","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1210\/jc.2015-2778","article-title":"Randomized controlled trial of preconception interventions in infertile women with polycystic ovary syndrome","volume":"100","author":"Legro","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib78","first-page":"1626","article-title":"Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial","volume":"86","author":"Azziz","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib79","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.fertnstert.2003.08.023","article-title":"A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome","volume":"81","author":"Stamets","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib80","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/cen.12175","article-title":"Favourable metabolic effects of a eucaloric lower-carbohydrate diet in women with PCOS","volume":"79","author":"Gower","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib81","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.fertnstert.2005.08.045","article-title":"Role of diet in the treatment of polycystic ovary syndrome","volume":"85","author":"Douglas","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib82","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.metabol.2014.07.007","article-title":"Effects of a eucaloric reduced-carbohydrate diet on body composition and fat distribution in women with PCOS","volume":"63","author":"Goss","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib83","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.nut.2014.03.008","article-title":"Effects of DASH diet on lipid profiles and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized clinical trial","volume":"30","author":"Asemi","year":"2014","journal-title":"Nutrition"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib84","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jand.2012.11.018","article-title":"Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines","volume":"113","author":"Moran","year":"2013","journal-title":"J Acad Nutr Diet"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib85","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3945\/ajcn.2010.29261","article-title":"Effect of a low glycemic index compared with a conventional healthy diet on polycystic ovary syndrome","volume":"92","author":"Marsh","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib86","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2307\/2626958","article-title":"Social conditions as fundamental causes of disease","author":"Link","year":"1995","journal-title":"J Health Soc Behav"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib87","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","article-title":"Polycystic ovary syndrome","volume":"370","author":"Norman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib88","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/epirev\/mxm007","article-title":"The obesity epidemic in the United States\u2014gender, age, socioeconomic, racial\/ethnic, and geographic characteristics: a systematic review and meta-regression analysis","volume":"29","author":"Wang","year":"2007","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib89","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/002214650504600103","article-title":"Neighborhood socioeconomic disadvantage and access to health care","volume":"46","author":"Kirby","year":"2005","journal-title":"J Health Soc Behav"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib90","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1476-069X-11-10","article-title":"Social disparities in exposures to bisphenol A and polyfluoroalkyl chemicals: a cross-sectional study within NHANES 2003\u20132006","volume":"11","author":"Nelson","year":"2012","journal-title":"Environ Health"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib91","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/1047-2797(94)90082-5","article-title":"Associations between measures of socioeconomic status and low birth weight, small for gestational age,\u00a0and premature delivery in the United States","volume":"4","author":"Parker","year":"1994","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib92","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1136\/bmj.325.7368.805","article-title":"Socioeconomic position in childhood and adulthood and insulin resistance: cross sectional survey using\u00a0data from British women\u2019s heart and health study","volume":"325","author":"Lawlor","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib93","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1089\/jwh.2010.2303","article-title":"Socioeconomic status and polycystic ovary syndrome","volume":"20","author":"Merkin","year":"2011","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib94","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.fertnstert.2008.02.161","article-title":"Influence of sociocultural factors on the ovulatory status of polycystic ovary syndrome","volume":"91","author":"di Fede","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib95","doi-asserted-by":"crossref","first-page":"J168","DOI":"10.1016\/j.jaut.2009.11.018","article-title":"Defining and analyzing geoepidemiology and human autoimmunity","volume":"34","author":"Shapira","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib96","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2471\/BLT.14.150565","article-title":"Increased food energy supply as a major driver of the obesity epidemic: a global analysis","volume":"93","author":"Vandevijvere","year":"2015","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib97","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/AOG.0b013e318202b0a4","article-title":"Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"117","author":"Dokras","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib98","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.fertnstert.2011.10.022","article-title":"Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis","volume":"97","author":"Dokras","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib99","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib100","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib101","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib102","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected caucasian women from Spain","volume":"85","author":"Asuncion","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib103","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2265.1999.00886.x","article-title":"Polycystic ovaries and associated clinical and biochemical features in young women","volume":"51","author":"Michelmore","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib104","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.fertnstert.2005.03.051","article-title":"Polycystic ovary syndrome in Mexican-Americans: prevalence and association with the severity of insulin resistance","volume":"84","author":"Goodarzi","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejogrb.2007.12.018","article-title":"Prevalence of polycystic ovary syndrome in unselected women from southern China","volume":"139","author":"Chen","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib106","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/j.1471-0528.2006.01008.x","article-title":"PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors","volume":"113","author":"Broekmans","year":"2006","journal-title":"BJOG"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib107","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib108","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1477-7827-9-39","article-title":"The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS Prevalence study","volume":"9","author":"Tehrani","year":"2011","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib109","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/aje\/kwn137","article-title":"A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka","volume":"168","author":"Kumarapeli","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib110","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1093\/humrep\/det262","article-title":"Prevalence of polycystic ovary syndrome in women in China: a large community-based study","volume":"28","author":"Li","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib111","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/jc.2005-2430","article-title":"Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome","volume":"91","author":"Lo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.05.011_bib112","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/01.JIM.0000446834.90599.5d","article-title":"Epidemiology and comorbidities of polycystic ovary syndrome in an indigent population","volume":"62","author":"Sirmans","year":"2014","journal-title":"J Investig Med"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216612785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216612785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T20:14:51Z","timestamp":1768680891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028216612785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":112,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0015028216612785"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.05.011","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Environmental determinants of\u00a0polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a92016 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}